Literature DB >> 31199760

Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis - a pilot study.

Ivar Tjernberg1,2, Marcus Johansson1,3, Anna J Henningsson1,4,5.   

Abstract

Background The aim of this study was to evaluate the diagnostic performance of cerebrospinal fluid (CSF) free light chains (FLCs) in the diagnosis of Lyme neuroborreliosis (LNB). Methods Serum and CSF levels of κ- and λ-FLC, albumin and total concentration of immunoglobulin M (IgM) were determined together with CSF chemokine CXCL13 in 23 patients with definite LNB, 35 inflammatory neurological disease control (INDC) and 18 non-inflammatory control (NIC) patients. Indices and intrathecal fractions (IFs) of FLC and IgM were calculated. Results Significant differences in FLC indices and IFs were found between the LNB group and both control groups, p ≤ 0.007. Sensitivity of intrathecal κ- and λ-FLC synthesis reached 78%-87% in LNB patients with a specificity of 94%-100% in NIC patients, whereas specificity in INDC patients was 69%. The corresponding frequencies of positive results for IF and index of IgM and CSF CXCL13 in these three diagnostic groups were 74%-96% in LNB patients, 0% in NIC patients and 3%-6% in INDC patients at the chosen cut-off levels. Conclusions The findings of this study show a moderate to high sensitivity of CSF κ- and λ-FLC in LNB patients with a high specificity in NIC patients. However, overlap in CSF κ- and λ-FLC levels between LNB and INDC patients calls for caution in the interpretation and limits the diagnostic usefulness in the LNB diagnosis. CSF CXCL13 appears to be the most valuable additional biomarker of LNB aside from routine parameters such as CSF pleocytosis and anti-Borrelia antibody index.

Entities:  

Keywords:  Lyme neuroborreliosis; cerebrospinal fluid; diagnosis; free light chain

Mesh:

Substances:

Year:  2019        PMID: 31199760     DOI: 10.1515/cclm-2019-0315

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  6 in total

1.  Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.

Authors:  Harald Hegen; Klaus Berek; Florian Deisenhammer
Journal:  Wien Med Wochenschr       Date:  2022-02-08

Review 2.  Immunoserological Diagnosis of Human Borrelioses: Current Knowledge and Perspectives.

Authors:  Emilie Talagrand-Reboul; Alice Raffetin; Pierre Zachary; Benoît Jaulhac; Carole Eldin
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 5.293

3.  Kappa Free Light Chains in the Context of Blood Contamination, and Other IgA- and IgM-Related Cerebrospinal Fluid Disease Pattern.

Authors:  Malte Johannes Hannich; Alexander Dressel; Kathrin Budde; Astrid Petersmann; Matthias Nauck; Marie Süße
Journal:  Cells       Date:  2021-03-11       Impact factor: 6.600

Review 4.  The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Kurt-Wolfram Sühs; Hayrettin Tumani; Marie Süße; Thomas Skripuletz
Journal:  Cells       Date:  2021-11-06       Impact factor: 6.600

5.  Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Torsten Witte; Kurt-Wolfram Sühs; Matthias Grothe; Malte Johannes Hannich; Marie Süße; Thomas Skripuletz
Journal:  Brain Sci       Date:  2022-04-03

6.  CXCL13 is elevated in inflammatory bowel disease in mice and humans and is implicated in disease pathogenesis.

Authors:  Ting Liu; Yu Liu; Chen-Xi Liu; Yong-Mei Jiang
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.